FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Fox & Friends: Janice Dean discusses FDA delay of promising MS drug: VIDEO




Janice Dean
Image Source: FOXNEWS

Fox News’ Janice Dean is one of the 2.3 million people worldwide living with MS. She appeared on Fox & Friends Friday with Nancy Davis, chairwoman of the Race to Erase MS organization to speak about why the FDA delayed the approval of Genentech’s ocrelizumab, a new drug being hailed as a medical breakthrough for MS patients. 

According to the National Multiple Sclerosis Society, MS is an unpredictable disease that attacks the central nervous system and disrupts the flow of information within the brain and between the brain and body. The severity of the disease cannot be predicted and most patients are diagnosed between the ages of 20 and 50.

“I think this drug is going to completely change the landscape of MS,” Davis, who was diagnosed with MS 25 years ago, told Fox & Friends. “It’s the first drug that suppresses your B cells, and they feel the B cells activate the T cells.”

The 14 drugs currently available for MS patients work to reverse the T cell reaction, whereas ocrelizumab works to stop it before it stops. The FDA was scheduled to issue a decision on the drug in December, but pushed it back until March

“It’s also the first drug that will help people with the more chronic, progressive and primary progressive MS,” Davis said. “Nothing has ever been able to specifically help people with that type of MS.”

Dean, who was diagnosed in 2005 and went public with the disease in 2008, thanked Davis for working with doctors to be proactive about the disease and said that she believes researchers are on the brink of finding a cure.

“I think we’re almost there,” Dean said. “If not a cure right now, a stop in the progression in the disease, which would be so helpful.” 


Story Source: The above story is based on materials provided by FOXNEWS
Note: Materials may be edited for content and length

Labels: , ,



Go to Newer News Go to Older News